VEGFA and neoplasm: Previously, an in vivo rat model, showed that anti-VEGF treatment leads to slower growth of intracranial glioblastoma tumors, however their histological evaluation revealed an increased invasive tumor growth and co-option of pre-existing vessels, indicating acquired strong resistance mechanisms to anti-angiogenic therapy (Rubenstein et al., 2000).